Last reviewed 2026-04-19 · How we verify

BG9928

Biogen · Phase 1 active Small molecule

At a glance

Generic name	BG9928
Sponsor	Biogen
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BG9928 CI brief — competitive landscape report
BG9928 updates RSS · CI watch RSS
Biogen portfolio CI